COST-EFFECTIVENESS OF PHARMACOTHERAPIES FOR NICOTINE DEPENDENCE IN PRIMARY CARE SETTINGS: A MULTINATIONAL COMPARISON

Podobne zapisy

• COSTS AND BENEFITS OF SMOKING CESSATION AIDS: MAKING A CASE FOR PUBLIC REIMBURSEMENT OF NICOTINE REPLACEMENT THERAPY IN AUSTRALIA
  od: BERTRAM, M.Y
  Wydane: (2007)
• COST EFFECTIVENESS OF DISULFIRAM: TREATING COCAINE USE IN METHADONE-MAINTAINED PATIENTS
  od: JOFRE-BONET, M.
  Wydane: (2004)
• A COST-EFFECTIVENESS ANALYSIS OF HEROIN DETOXIFICATION METHODS IN THE AUSTRALIAN NATIONAL EVALUATION OF PHARMACOTHERAPIES FOR OPIOID DEPENDENCE (NEPOD)
  od: SHANAHAN, M.D
  Wydane: (2006)
• A RAW DEAL? IMPACT ON THE HEALTH OF CONSUMERS RELATIVE TO THE COST OF PHARMACOTHERAPY
  od: ROWE, J.
  Wydane: (2008)
• COST ANALYSIS OF CLINIC AND OFFICE-BASED TREATMENT OF OPIOID DEPENDENCE: RESULTS WITH METHADONE AND BUPRENORPHINE IN CLINICALLY STABLE PATIENTS
  od: JONES, E.S
  Wydane: (2009)